Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Colorectal Neoplasms × sacituzumab govitecan × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Metastatic Urothelial Cancer 1 Glioblastoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Cetuximab 5 Bevacizumab 4 pembrolizumab 3 Leucovorin 3 Irinotecan 3 Fluorouracil 3 trifluridine tipiracil drug combination 2 trastuzumab deruxtecan 2 encorafenib 2 Oxaliplatin 2 HMPL-013 2 tucatinib 1 sotorasib 1 regorafenib 1 pralsetinib 1 larotrectinib 1 entrectinib 1 binimetinib 1 adagrasib 1 Trastuzumab 1 Panitumumab 1 Nivolumab 1 Levoleucovorin 1 Ipilimumab 1 IFL protocol 1 Capecitabine 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡